Beacon Pointe Advisors’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.37M Buy
30,359
+995
+3% +$77.8K 0.02% 457
2025
Q1
$2.13M Sell
29,364
-3,472
-11% -$252K 0.02% 445
2024
Q4
$2.43M Sell
32,836
-952
-3% -$70.5K 0.03% 417
2024
Q3
$2.23M Sell
33,788
-3,858
-10% -$255K 0.03% 445
2024
Q2
$3.48M Sell
37,646
-1,302
-3% -$120K 0.04% 353
2024
Q1
$3.72M Sell
38,948
-1,086
-3% -$104K 0.04% 361
2023
Q4
$3.05M Sell
40,034
-4,468
-10% -$341K 0.04% 390
2023
Q3
$3.08M Buy
44,502
+4,596
+12% +$318K 0.04% 363
2023
Q2
$3.76M Buy
39,906
+2,718
+7% +$256K 0.06% 266
2023
Q1
$3.08M Sell
37,188
-258
-0.7% -$21.3K 0.05% 303
2022
Q4
$2.79M Sell
37,446
-906
-2% -$67.6K 0.05% 294
2022
Q3
$3.16M Sell
38,352
-9,389
-20% -$774K 0.07% 230
2022
Q2
$4.54M Sell
47,741
-27,514
-37% -$2.61M 0.1% 195
2022
Q1
$8.86M Buy
75,255
+43,655
+138% +$5.14M 0.12% 171
2021
Q4
$4.09M Sell
31,600
-41,804
-57% -$5.42M 0.11% 164
2021
Q3
$8.31M Buy
73,404
+48,392
+193% +$5.48M 0.21% 119
2021
Q2
$2.59M Buy
25,012
+894
+4% +$92.6K 0.09% 186
2021
Q1
$2.02M Sell
24,118
-2,619
-10% -$219K 0.12% 145
2020
Q4
$2.44M Buy
26,737
+2,738
+11% +$250K 0.17% 117
2020
Q3
$1.92M Buy
23,999
+8
+0% +$639 0.19% 105
2020
Q2
$1.66M Sell
23,991
-117
-0.5% -$8.08K 0.17% 117
2020
Q1
$1.52M Buy
24,108
+16,356
+211% +$1.03M 0.24% 89
2019
Q4
$602K Buy
7,752
+543
+8% +$42.2K 0.19% 109
2019
Q3
$528K Sell
7,209
-1,074
-13% -$78.7K 0.23% 99
2019
Q2
$512K Buy
8,283
+1,128
+16% +$69.7K 0.19% 116
2019
Q1
$458K Buy
7,155
+1,032
+17% +$66.1K 0.17% 119
2018
Q4
$312K Buy
+6,123
New +$312K 0.19% 119